MJ, T., M, V., KA, M., JR, B., & SB, B. (2020). The emerging role of epigenetic therapeutics in immuno-oncology. Nature reviews. Clinical oncology, 17(2), 75. https://doi.org/10.1038/s41571-019-0266-5
Chicago Style (17th ed.) CitationMJ, Topper, Vaz M, Marrone KA, Brahmer JR, and Baylin SB. "The Emerging Role of Epigenetic Therapeutics in Immuno-oncology." Nature Reviews. Clinical Oncology 17, no. 2 (2020): 75. https://doi.org/10.1038/s41571-019-0266-5.
MLA (9th ed.) CitationMJ, Topper, et al. "The Emerging Role of Epigenetic Therapeutics in Immuno-oncology." Nature Reviews. Clinical Oncology, vol. 17, no. 2, 2020, p. 75, https://doi.org/10.1038/s41571-019-0266-5.
Warning: These citations may not always be 100% accurate.